OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain-computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is competitor in the growing brain-implant ...
Add Yahoo as a preferred source to see more of our stories on Google. Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient last ...
Fallout season two is kicking off with a bang… Literally, if you’re one of a few unlucky people who cross paths with Mr. House or Hank MacLean. But what is that’s making people’s heads go bang? We ...
OpenAI recently confirmed that it has invested in its co-founder Sam Altman's Merge Labs, a brain computer interface startup.
Elon Musk's startup Neuralink has successfully implanted its brain-computer interface into a man named Brad Smith, who has ALS and is completely non-verbal, allowing him to communicate now using ...
In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...
Elon Musk announces Neuralink brain implants will enter "high-volume" production by 2026, helping paralyzed patients control ...
Neuralink, a leader in the fledgling field of brain implants, is hurting the industry's efforts to develop useful medical ...
What Is Mr. House’s Brain-Computer Interface Implant Chip, and When Do We See It Used? Mr. House’s Brain-Computer Interface Implant Chip is one of the first things we see on Fallout season two. We ...
New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...
Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) field ARC-BCI Therapy is designed to restore thought-driven movement after spinal cord ...
An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...